|Mr. Fabio Chianelli||CEO & Chairman||N/A||N/A||1978|
|Mr. Carmelo Marrelli CPA, B.Comm., CA, CGA, ACIS||Chief Financial Officer||N/A||N/A||1971|
|Andrew Todd||Corp. Sec.||N/A||N/A||N/A|
Newscope Capital Corporation, through its subsidiary, PharmaTher Inc., a specialty life sciences company, focuses on the research and development of psychedelic pharmaceuticals to treat neuropsychiatric, neurological, and neuromuscular diseases. The company is headquartered in Toronto, Canada.
PharmaTher Holdings Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.